Key result
RV-predominant cardiogenic shock requires early multimodal management with tailored inotropes, volume control, and MCS.
Why the study?
Research has primarily focused on cardiogenic shock due to left-sided pathology, leaving right-sided pathology, its clinical state, and treatment less assessed.
Provides a focused clinical overview on the diagnosis and specialized management of right ventricular cardiogenic shock, emphasizing hemodynamic assessment and targeted therapies.
May guide RV-predominant shock management; leaves open optimal protocols pending prospective trials.
Cardiogenic shock (CS) remains a highly lethal condition despite many efforts and new interventions. Patients presenting with a rapid onset of hemodynamic instability and subsequent collapse require prompt and appropriate multimodality treatment. Multiple etiologies can lead to heart failure and subsequent shock. As the case prevalence of heart failure increases worldwide, it is of great importance to explore all manners and protocols of presentation and treatment present. With research primarily focusing on CS due to cardiac left-sided pathology, few assessments of right-sided pathology and the subsequent clinical state and treatment have been conducted. This review aims to present an in-depth assessment of the currently available literature, assessing the pathophysiology, presentation and management of CS patients due to right heart failure.
No takes yet. Share an insight, caveat, or question.
Copeland et al. (2023) conducted a review in Right Ventricle-Predominant Cardiogenic Shock. Right heart failure management strategies was evaluated. Right ventricle-predominant cardiogenic shock requires prompt, targeted multimodality treatment, including specific inotropic support, precise volume maintenance, and early mechanical support.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: